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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idFigure 1. Clinical features of the ‘‘mucous patches’’ form. Slightly and oval elevated plaques, sometimes ulcerate, covered with a white or gray pseudomembrane in the soft
palate and labial mucosa.
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S U M M A R Y
Known as ‘‘the great imitator,’’ secondary syphilis may clinically manifest itself in myriad ways,
involving different organs including the oral mucosa, and mimicking, both clinically and histologically,
several diseases, thereby making diagnosis a challenge for clinicians. We highlight the clinical aspects of
oral manifestation in 7 patients with secondary syphilis. Clinicians should consider secondary syphilis in
the differential diagnosis of ulcerative and/or white oral lesions.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Figure 3. Clinical features of the ‘‘leukoplakia-like’’ form. A well delimited raised surface that was a corrugated, nonhomogeneous white plaque in oral mucosa of two distinct
patients.
Figure 2. Clinical features of the ‘‘mucous patches’’ form. Serpiginous lesions affecting oral mucosa, described as snail track ulcers.
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Syphilis is an acute and chronic sexually transmitted disease which
is caused by an anaerobic tightly coiled helical bacterial species,
Treponema pallidum.1–4 On the basis of its activity and infectivity
phase, acquired syphilis can be classiﬁed into four stages: primary,
secondary, latent, and tertiary.3,4 Oral lesions are principally
associated with secondary syphilis, although all stages can give rise
to oral manifestations.1,2 This wide array of manifestations has given
syphilis the reputation as the ‘‘great imitator’’.Table 1
Description of clinical data of patients with secondary syphilis.
Patient Age Sex Medical history Site Typ
1 19 Male Skin lesions Hard palate, inferior lip and
tongue
Mu
2 40 Female No Inferior and superior lip Mu
3 25 Female Genital lesion Buccal mucosa and tongue Mu
4 32 Male No Buccal mucosa and superior lip Mu
5 9 Female Skin lesions Inferior lip and tongue Mu
6 29 Male Genital lesion Buccal mucosa and tongue ‘‘Le
7 21 Female Genital lesion Hard palate and inferior lip ‘‘Le
VDRL, Venereal Disease Research Laboratory; FTA-Abs, ﬂuorescent treponemal antibodSeveral clinical forms are described for the secondary syphilis
affecting oral mucosa, among which the most common is called
‘‘mucous patches’’ with two subtypes: slightly elevated-type
plaques and, occasionally, ulcerated, which are usually oval and
covered with a gray or white pseudomembrane; or multiple mucous
patches that may coalesce to give rise to serpiginous lesions,
described as snail track ulcers. White plaques with verrucous aspect,
so-called ‘‘leukoplakia like’’ are also described as another frequent
form of disease. However, some cases can manifest atypically, and
the diagnosis can be delayed or even missed.1,2e of manifestation Serological test PB treatment
cous Patches VDRL+ 1/8 / FTA-ABS + 2,400,000 UI, single dose
cous Patches VDRL+ 1/32 / FTA-ABS + 2,400,000 UI, single dose
cous Patches VDRL - / FTA-ABS + 2,400,000 UI, single dose
cous Patches VDRL+ 1/128 / FTA-ABS + 1,200,000 UI 4 times,
weekly interval
cous Patches VDRL - / FTA-ABS + 2,400,000 UI, single dose
ukoplakia-like’’ plaque VDRL+ 1/64 / FTA-ABS + 2,400,000 UI, single dose
ukoplakia-like’’ plaque VDRL+ 1/32 / FTA-ABS + 1,200,000 UI 4 times,
weekly interval
y absorption; PB, penicillin benzathin.
Medical Imagery / International Journal of Infectious Diseases 35 (2015) 40–4242Table 1 summarizes the clinical proﬁles, serologic results,
and treatment modalities of 7 patients with secondary syphilis
(Figs. 1–3). The patients presented here were referred for serologic
testing, which revealed a positive result for syphilis (Venereal
Disease Research Laboratory [VDRL] positive, Fluorescent Trepo-
nemal Antibody [FTA-Abs] positive, Treponema pallidum IgM
positive). Therapy with benzathine-penicillin, administered intra-
muscularly led to complete remission of oral lesions and other
symptoms in all patients.
Medical practitioners should consider secondary syphilis in the
differential diagnosis of white and ulcerative oral lesions,
particularly in at-risk groups, and ask questions regarding the
development of lesions after sexual activity.1,2
Conﬂict of interest: No conﬂict of interest to declare.
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